A Randomized Unblinded Feasibility Study Evaluating the Use of Oral Administration of MB-102 versus Dual Sugar Testing for Gut Permeability in Normal Subjects and Subjects with Active Small Bowel Crohn's Disease

    Not Recruiting
Updated on 22 September 2021


This is a phase I feasibility study to evaluate the use of MB-102 as a means to test intestinal permeability (the ability of a substance to allow another substance to pass through it). MB-102 has critical similarities to the compounds used in dual sugar testing; mainly molecular weight and excretion exclusively via glomerular filtration (the first step in making urine).
An evaluation that compares the spectrum of MB-102 excreted in normal subjects and subject's with active Crohn's disease vs results obtained from those same subjects undergoing dual sugar testing will determine if further development of MB-102 and a sensor device to detect skin fluorescence is feasible in this indication.


Condition *Healthy Volunteers
Clinical Study IdentifierTX228538
Last Modified on22 September 2021

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note